DK1641436T3 - Inhalerbar aztreonamlysinatformulering til behandling af og forebyggelse mod bakterielle lungeinfektioner - Google Patents
Inhalerbar aztreonamlysinatformulering til behandling af og forebyggelse mod bakterielle lungeinfektionerInfo
- Publication number
- DK1641436T3 DK1641436T3 DK04777564.8T DK04777564T DK1641436T3 DK 1641436 T3 DK1641436 T3 DK 1641436T3 DK 04777564 T DK04777564 T DK 04777564T DK 1641436 T3 DK1641436 T3 DK 1641436T3
- Authority
- DK
- Denmark
- Prior art keywords
- inherable
- aztreon
- amlysinate
- formation
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/613,639 US7214364B2 (en) | 2000-12-27 | 2003-07-03 | Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
| US10/882,985 US7138419B2 (en) | 2000-12-27 | 2004-06-30 | Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinate |
| PCT/US2004/021517 WO2005007132A1 (en) | 2003-07-03 | 2004-07-01 | Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK1641436T3 true DK1641436T3 (da) | 2013-09-30 |
| DK1641436T4 DK1641436T4 (da) | 2017-07-17 |
Family
ID=34083679
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK09015300.8T DK2158901T3 (da) | 2003-07-03 | 2004-07-01 | Alpha-aztreonamlysinat |
| DK04777564.8T DK1641436T4 (da) | 2003-07-03 | 2004-07-01 | Inhalerbar aztreonamlysinatformulering til behandling af og forebyggelse mod bakterielle lungeinfektioner |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK09015300.8T DK2158901T3 (da) | 2003-07-03 | 2004-07-01 | Alpha-aztreonamlysinat |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7138419B2 (da) |
| EP (3) | EP2452672A3 (da) |
| JP (1) | JP2007527398A (da) |
| BR (1) | BRPI0411949A (da) |
| CA (1) | CA2530774C (da) |
| CY (2) | CY1114621T1 (da) |
| DK (2) | DK2158901T3 (da) |
| ES (2) | ES2428030T5 (da) |
| HK (1) | HK1089359A1 (da) |
| HU (2) | HUE035150T2 (da) |
| PL (2) | PL2158901T3 (da) |
| PT (2) | PT1641436E (da) |
| SI (2) | SI1641436T2 (da) |
| WO (1) | WO2005007132A1 (da) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7214364B2 (en) * | 2000-12-27 | 2007-05-08 | Corus Pharma, Inc. | Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
| US7138419B2 (en) † | 2000-12-27 | 2006-11-21 | Corus Pharma, Inc. | Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinate |
| CA2433280C (en) * | 2000-12-27 | 2010-09-21 | Salus Pharma, Inc. | Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections |
| ES2351651B2 (es) * | 2003-07-02 | 2011-09-28 | Gilead Sciences Inc. | Método para la determinación de impurezas en una sal de lisina de aztreonám amorfa. |
| WO2005005424A1 (en) * | 2003-07-02 | 2005-01-20 | TEVA Gyógyszergyár Részvénytársaság | Aztreonam l-lysine and methods for the preparation thereof |
| US8158152B2 (en) * | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
| CN101951906A (zh) * | 2007-10-01 | 2011-01-19 | 吉里德科学公司 | 用于治疗肺病中的健康相关生命质量缺陷的吸入式氨曲南赖氨酸 |
| CN101912356B (zh) * | 2010-08-02 | 2012-01-11 | 王明 | 一种氨曲南/精氨酸药物组合物脂微球注射剂 |
| ES2956367T3 (es) * | 2010-09-17 | 2023-12-20 | Technophage Investig E Desenvolvimento Em Biotecnologia Sa | Fago antibacteriano, péptidos de fago y sus métodos de uso |
| US10105356B2 (en) | 2011-01-31 | 2018-10-23 | Avalyn Pharma Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
| AU2012212269B2 (en) * | 2011-01-31 | 2016-05-19 | Avalyn Pharma Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
| AU2014239959A1 (en) * | 2013-03-14 | 2015-10-01 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
| CN104784159A (zh) * | 2015-04-15 | 2015-07-22 | 苏州惠仁生物科技有限公司 | 氨曲南粉雾剂的制备方法 |
| CN107805618B (zh) * | 2017-12-03 | 2021-04-06 | 李峰 | 一种改造盐碱地耕种性的微生物菌剂及其制备方法 |
| CN110857474B (zh) * | 2018-08-24 | 2023-04-18 | 武汉远大弘元股份有限公司 | L-半胱氨酸盐酸盐一水合物的处理方法 |
| US20220142866A1 (en) * | 2019-02-28 | 2022-05-12 | Exorao Life Science S.R.L. | Sterile aztreonam package |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9126A (en) * | 1852-07-13 | Marcus r | ||
| US3984403A (en) † | 1972-06-30 | 1976-10-05 | Takeda Chemical Industries, Ltd. | Arginine and lysine salts of acid cephalosporins |
| US4775670A (en) | 1980-09-29 | 1988-10-04 | E. R. Squibb & Sons, Inc. | 2-oxo-1-azetidinesulfonic acid salts |
| WO1982001873A1 (en) | 1980-12-05 | 1982-06-10 | Takeda Chemical Industries Ltd | 1-sulfo-2-oxoazetidine derivatives and process for their preparation |
| US4673739A (en) | 1980-12-05 | 1987-06-16 | Takeda Chemical Industries, Ltd. | 4-carbamoyloxymethyl-1-sulfo-2-oxoazetidine derivatives and their production |
| US4572801A (en) | 1981-04-30 | 1986-02-25 | Takeda Chemical Industries, Ltd. | 4-Carbamoyloxymethyl-1-sulfo-2-oxoazetidine derivatives and their production |
| US4946838A (en) | 1981-07-13 | 1990-08-07 | E. R. Squibb & Sons, Inc. | Crystalline anhydrous aztreonam |
| US4826973A (en) | 1984-07-20 | 1989-05-02 | E. R. Squibb & Sons, Inc. | Delta form of aztreonam and preparation thereof |
| US4610824A (en) | 1984-10-09 | 1986-09-09 | E. R. Squibb & Sons, Inc. | Hydrazide derivatives of monocyclic beta-lactam antibiotics |
| US4888998A (en) | 1986-07-11 | 1989-12-26 | Beckman Instruments, Inc. | Sample handling system |
| CA1339136C (en) | 1987-07-01 | 1997-07-29 | Sailesh Amilal Varia | Amorphous form of aztreonam |
| DK0754050T3 (da) | 1994-01-14 | 2002-10-21 | Xoma Technology Ltd | Anti-gram-positive bakterielle fremgangsmåder og materialer |
| US5875776A (en) | 1996-04-09 | 1999-03-02 | Vivorx Pharmaceuticals, Inc. | Dry powder inhaler |
| US5994340A (en) | 1997-08-29 | 1999-11-30 | Synphar Laboratories, Inc. | Azetidinone derivatives as β-lactamase inhibitors |
| ATE461692T1 (de) | 1999-10-29 | 2010-04-15 | Novartis Ag | Trockenpulverzusammensetzungen mit verbesserter dispersität |
| CA2433280C (en) * | 2000-12-27 | 2010-09-21 | Salus Pharma, Inc. | Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections |
| US7138419B2 (en) † | 2000-12-27 | 2006-11-21 | Corus Pharma, Inc. | Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinate |
| WO2003035030A1 (en) * | 2001-10-24 | 2003-05-01 | Pari Gmbh | Kit for the preparation of a pharmaceutical composition |
| JP2005525375A (ja) | 2002-03-05 | 2005-08-25 | トランセイブ， インク． | 生物活性物質をリポソーム又は脂質複合体内に封入する方法 |
| EP1417958A1 (en) * | 2002-11-08 | 2004-05-12 | Pari GmbH | Wet granulation process |
| WO2004052333A1 (en) * | 2002-12-11 | 2004-06-24 | Pari Gmbh | Pharmaceutical compositions for the pulmonary delivery of aztreonam |
| WO2005005424A1 (en) * | 2003-07-02 | 2005-01-20 | TEVA Gyógyszergyár Részvénytársaság | Aztreonam l-lysine and methods for the preparation thereof |
-
2004
- 2004-06-30 US US10/882,985 patent/US7138419B2/en not_active Expired - Lifetime
- 2004-07-01 EP EP12154996.8A patent/EP2452672A3/en not_active Withdrawn
- 2004-07-01 BR BRPI0411949-5A patent/BRPI0411949A/pt not_active Application Discontinuation
- 2004-07-01 EP EP04777564.8A patent/EP1641436B2/en active Active
- 2004-07-01 HU HUE09015300A patent/HUE035150T2/en unknown
- 2004-07-01 ES ES04777564.8T patent/ES2428030T5/es active Active
- 2004-07-01 SI SI200432105T patent/SI1641436T2/sl unknown
- 2004-07-01 PT PT47775648T patent/PT1641436E/pt unknown
- 2004-07-01 CA CA2530774A patent/CA2530774C/en active Active
- 2004-07-01 PT PT90153008T patent/PT2158901T/pt unknown
- 2004-07-01 PL PL09015300T patent/PL2158901T3/pl unknown
- 2004-07-01 EP EP09015300.8A patent/EP2158901B1/en active Active
- 2004-07-01 SI SI200432421T patent/SI2158901T1/en unknown
- 2004-07-01 DK DK09015300.8T patent/DK2158901T3/da active
- 2004-07-01 JP JP2006518827A patent/JP2007527398A/ja active Pending
- 2004-07-01 PL PL04777564T patent/PL1641436T5/pl unknown
- 2004-07-01 DK DK04777564.8T patent/DK1641436T4/da active
- 2004-07-01 ES ES09015300.8T patent/ES2655036T3/es active Active
- 2004-07-01 WO PCT/US2004/021517 patent/WO2005007132A1/en active Application Filing
-
2006
- 2006-08-29 HK HK06109627.6A patent/HK1089359A1/xx active IP Right Maintenance
-
2013
- 2013-11-18 CY CY20131101018T patent/CY1114621T1/el unknown
-
2017
- 2017-12-28 CY CY20171101351T patent/CY1119753T1/el unknown
-
2018
- 2018-02-21 HU HUS1800012C patent/HUS1800012I1/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2158901B1 (en) | 2017-10-18 |
| PT1641436E (pt) | 2013-11-07 |
| EP1641436A1 (en) | 2006-04-05 |
| SI1641436T1 (sl) | 2013-12-31 |
| SI2158901T1 (en) | 2018-02-28 |
| BRPI0411949A (pt) | 2006-08-29 |
| ES2428030T3 (es) | 2013-11-05 |
| WO2005007132A1 (en) | 2005-01-27 |
| EP2452672A3 (en) | 2013-11-06 |
| PL1641436T3 (pl) | 2014-02-28 |
| US7138419B2 (en) | 2006-11-21 |
| EP1641436B2 (en) | 2017-05-10 |
| CY1114621T1 (el) | 2016-10-05 |
| PL1641436T5 (pl) | 2017-10-31 |
| HUE035150T2 (en) | 2018-05-02 |
| CY1119753T1 (el) | 2018-06-27 |
| SI1641436T2 (sl) | 2017-08-31 |
| DK2158901T3 (da) | 2018-01-15 |
| DK1641436T4 (da) | 2017-07-17 |
| EP1641436B1 (en) | 2013-09-04 |
| PT2158901T (pt) | 2018-01-15 |
| EP2452672A2 (en) | 2012-05-16 |
| JP2007527398A (ja) | 2007-09-27 |
| PL2158901T3 (pl) | 2018-05-30 |
| HK1089359A1 (en) | 2006-12-01 |
| EP2158901A2 (en) | 2010-03-03 |
| ES2655036T3 (es) | 2018-02-16 |
| CA2530774A1 (en) | 2005-01-27 |
| EP2158901A3 (en) | 2010-03-17 |
| US20050063912A1 (en) | 2005-03-24 |
| HUS1800012I1 (hu) | 2018-03-28 |
| ES2428030T5 (es) | 2017-07-25 |
| CA2530774C (en) | 2011-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3159357T3 (da) | Sammensætning og fremgangsmåde til behandling og forebyggelse af enteriske bakterielle infektioner | |
| DK1658055T3 (da) | Indgivelsesform sikret mod misbrug | |
| DK1842533T3 (da) | Indgivelsesform sikret mod misbrug | |
| DK1641436T3 (da) | Inhalerbar aztreonamlysinatformulering til behandling af og forebyggelse mod bakterielle lungeinfektioner | |
| NO20053974D0 (no) | Tienopyrimidinforbindelser og anvendelse derav. | |
| DK1601689T3 (da) | Oprensningsfremgangsmåde for bakterielt cytolysin | |
| DK1592686T3 (da) | Gyrase-inhibitorer og anvendelser deraf | |
| NO20032220D0 (no) | Löfteverktöy II og fremgangsmåte for anvendelse av samme | |
| DK1565478T3 (da) | Polysaccharidvaccine mod stafylokokinfektioner | |
| ZA200507070B (en) | Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections | |
| DK1628530T3 (da) | Fremgangsmåder og sammensætninger til forebyggelse og behandling af sepsis | |
| EP1812068A4 (en) | METHODS FOR PREVENTING AND TREATING RSV INFECTIONS AND ASSOCIATED DISEASES | |
| NO20052362D0 (no) | Fremgangsmater for administrering av dalbavancin for behandling av bakterielle infeksjoner | |
| NO20025204D0 (no) | Forbindelser og fremgangsmÕter for behandling og forebygging av bakterielle infeksjoner | |
| WO2003088897A3 (en) | Fab i inhibitors | |
| DK2262280T3 (da) | Fremgangsmåde og system til beskyttelse mod akustisk chok | |
| ZA200604412B (en) | Bacterial virulence factors and uses thereof | |
| DK1603915T3 (da) | Substituerede 8-pyridinyl-dihydrospiro-cycloalkyl-pyrimido- 1,2-a-pyrimidin-6-on og 8-pyrimidinyl-dihydrospiro-cycloalkyl-pyrimido-1,2-a-pyrimidin-6-on-derivater og deres anvendelse mod neurogenerative sygdomme | |
| DE602004010856D1 (de) | Bohrlochbehandlungsflüssigkeiten | |
| DK1694342T3 (da) | Fremgangsmåder til anvendelse af gelsolin til behandling eller forebyggelse af bakteriel sepsis | |
| IL180459A0 (en) | Treatment of bacterial infections | |
| DE502004002283D1 (de) | Pasteurisierungsanlage | |
| DK1656143T3 (da) | Quinolon-antibiotika til behandling af periodontale infektioner | |
| DE602004010464D1 (de) | Videoverarbeitung | |
| NO20043445L (no) | Kombinasjonsterapi for behandling av bakterielle infeksjoner |